BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 32913581)

  • 1. Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike.
    Trigueiro-Louro J; Correia V; Figueiredo-Nunes I; Gíria M; Rebelo-de-Andrade H
    Comput Struct Biotechnol J; 2020; 18():2117-2131. PubMed ID: 32913581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single domain antibodies derived from ancient animals as broadly neutralizing agents for SARS-CoV-2 and other coronaviruses.
    Lim HT; Kok BH; Lim CP; Abdul Majeed AB; Leow CY; Leow CH
    Biomed Eng Adv; 2022 Dec; 4():100054. PubMed ID: 36158162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes.
    Guo H; Hu BJ; Yang XL; Zeng LP; Li B; Ouyang S; Shi ZL
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32699095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.
    Xia S; Liu M; Wang C; Xu W; Lan Q; Feng S; Qi F; Bao L; Du L; Liu S; Qin C; Sun F; Shi Z; Zhu Y; Jiang S; Lu L
    Cell Res; 2020 Apr; 30(4):343-355. PubMed ID: 32231345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice.
    Liu MQ; Jiang RD; Guo J; Chen Y; Yang DS; Wang X; Lin HF; Li A; Li B; Hu B; Wang ZJ; Yang XL; Shi ZL
    J Virol; 2022 Apr; 96(8):e0016922. PubMed ID: 35343762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
    Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 442th amino acid residue of the spike protein is critical for the adaptation to bat hosts for SARS-related coronaviruses.
    Li JY; Wang Q; Liao CH; Qiu Y; Ge XY
    Virus Res; 2021 Apr; 295():198307. PubMed ID: 33476695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the Fusion Peptide-Containing Region in Betacoronavirus Spike Glycoproteins.
    Ou X; Zheng W; Shan Y; Mu Z; Dominguez SR; Holmes KV; Qian Z
    J Virol; 2016 Jun; 90(12):5586-5600. PubMed ID: 27030273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and Genomic Characterization of Two Novel SARS-Related Coronaviruses in Horseshoe Bats from Guangdong, China.
    Li L; Zhang L; Zhou J; He X; Yu Y; Liu P; Huang W; Xiang Z; Chen J
    mBio; 2022 Jun; 13(3):e0046322. PubMed ID: 35467426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states.
    Peters MH; Bastidas O; Kokron DS; Henze CE
    PLoS One; 2020; 15(11):e0241168. PubMed ID: 33170884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus.
    Hu B; Zeng LP; Yang XL; Ge XY; Zhang W; Li B; Xie JZ; Shen XR; Zhang YZ; Wang N; Luo DS; Zheng XS; Wang MN; Daszak P; Wang LF; Cui J; Shi ZL
    PLoS Pathog; 2017 Nov; 13(11):e1006698. PubMed ID: 29190287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses
    Vishwakarma P; Yadav N; Rizvi ZA; Khan NA; Chiranjivi AK; Mani S; Bansal M; Dwivedi P; Shrivastava T; Kumar R; Awasthi A; Ahmed S; Samal S
    Front Immunol; 2021; 12():613045. PubMed ID: 33841395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.
    Farouk AE; Baig MH; Khan MI; Park T; Alotaibi SS; Dong JJ
    Saudi J Biol Sci; 2021 Jun; 28(6):3262-3269. PubMed ID: 33654454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.
    Sui J; Deming M; Rockx B; Liddington RC; Zhu QK; Baric RS; Marasco WA
    J Virol; 2014 Dec; 88(23):13769-80. PubMed ID: 25231316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the Receptor-Binding Domain of the Spike Glycoprotein of Human Betacoronavirus HKU1.
    Qian Z; Ou X; Góes LG; Osborne C; Castano A; Holmes KV; Dominguez SR
    J Virol; 2015 Sep; 89(17):8816-27. PubMed ID: 26085157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
    Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
    J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
    Zhu Y; Yu D; Yan H; Chong H; He Y
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe Acute Respiratory Syndrome (SARS) Coronavirus ORF8 Protein Is Acquired from SARS-Related Coronavirus from Greater Horseshoe Bats through Recombination.
    Lau SK; Feng Y; Chen H; Luk HK; Yang WH; Li KS; Zhang YZ; Huang Y; Song ZZ; Chow WN; Fan RY; Ahmed SS; Yeung HC; Lam CS; Cai JP; Wong SS; Chan JF; Yuen KY; Zhang HL; Woo PC
    J Virol; 2015 Oct; 89(20):10532-47. PubMed ID: 26269185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highlight of potential impact of new viral genotypes of SARS-CoV-2 on vaccines and anti-viral therapeutics.
    Ghorbani A; Samarfard S; Jajarmi M; Bagheri M; Karbanowicz TP; Afsharifar A; Eskandari MH; Niazi A; Izadpanah K
    Gene Rep; 2022 Mar; 26():101537. PubMed ID: 35128175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying promising druggable binding sites and their flexibility to target the receptor-binding domain of SARS-CoV-2 spike protein.
    Ghoula M; Naceri S; Sitruk S; Flatters D; Moroy G; Camproux AC
    Comput Struct Biotechnol J; 2023; 21():2339-2351. PubMed ID: 36998674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.